Price $86.44 |
Market Cap
5.71B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
47.1
|
P/B
1.15
|
P/S
1.85
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
13.1
|
Op. Cash Flow
573.2K
|
FCF
6.5
|
|
Op. Margin
9.60%
|
Net Margin
3.80%
|
ROE
2.40%
|
ROI
8.40%
|
|
ROA
1.30%
|
EPS Growth
-91.60%
|
Current Ratio
1.6
|
Debt/Equity
49.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Champions Oncology Inc (CSBR) | $5.55 | - | - | 67.8M | Strong Buy |
| Bellerophon Therapeutics Inc (BLPH) | $0.83 | - | - | 72M | Strong Buy |
| Baxter International Inc (BAX) | $42.14 | - | 2.80% | 20.86B | Strong Buy |
| Star Equity Holdings Inc (STRR) | $1.09 | - | - | 16M | Strong Buy |
| Palatin Technologies, Inc. (PTN) | $2.28 | - | - | 26.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
